Masoud Ahmadzad-Asl

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND Medication treatment compliance among bipolar patients is quite widespread. OBJECTIVES Treatment compliance depends on multiple factors. The aim of this study was to evaluate the predicting factors of noncompliance in patients with bipolar I disorder admitted to an Iranian hospital during a six-month follow up period. MATERIALS AND METHODS(More)
OBJECTIVES To assess and compare demographic and diagnostic characteristics of inpatients with mood disorders in Iran. MATERIALS AND METHODS We collected the demographic, clinical, and treatment characteristics of patients, who were hospitalized during five years from April 2006 to March 2010, in Iran hospital of psychiatry, a residency training center to(More)
BACKGROUND We have assessed the role of stress on compliance of patients with diabetes mellitus (DM) and hypertension (HTN) with taking prescribed medications and following dietary and exercise regimens. METHODS A total of 9544 individuals more than 19 years of age were selected from three counties in central Iran. The presence of DM and HTN were asked(More)
BACKGROUND Patients' characteristics influence the disorders outcome, so it is valuable to compare mood disorders and inpatients' attributes in different large samples. OBJECTIVES This study was designed to assess demographic and diagnostic characteristics of 3000 Iranian inpatient with bipolar disorders. PATIENTS AND METHODS We collected the(More)
OBJECTIVE The present study aimed to review the relapse rate in patients with schizophrenia treated with orally taken atypical agents (serotonin dopamine antagonists, SDAs) and depot preparation of conventional (typical) antipsychotics. METHODS In this historical cohort study, mean relapse per month (MRM) index, duration between initiation of(More)
OBJECTIVE To compare the effectiveness and safety of the methylphenidate produced in Iran (Stimdate®) with its original brand (Ritalin®) in children with Attention deficit hyperactivity disorder (ADHD). METHODS In this double-blinded randomized clinical trial, 30 patients with ADHD who were 6 to 16 years old, were divided into two groups: 15 in Stimdate®(More)
  • 1